March 19, 2024CorporateTerumo Blood and Cell Technologies partners with CiRA Foundation to develop automated iPS cell manufacturingiPS cell manufacturing organization researchers to integrate Terumo Blood and Cell Technologies’ Quantum Flex, expertise through collaboration
March 11, 2024FinancialNotice Concerning the Status and Completion of the Acquisition of Own Shares and Cancellation of Treasury Stock (PDF 130.35 KB)
March 11, 2024FinancialNotice Concerning Partial Amendment to “Notice Concerning Share Split and Partial Amendment to the Articles of Incorporation” (PDF 115.61 KB)
Refining Searches 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Corporate Financial March 19, 2024 Corporate Terumo Blood and Cell Technologies partners with CiRA Foundation to develop automated iPS cell manufacturing iPS cell manufacturing organization researchers to integrate Terumo Blood and Cell Technologies’ Quantum Flex, expertise through collaboration March 11, 2024 Financial Notice Concerning Partial Amendment to “Notice Concerning Share Split and Partial Amendment to the Articles of Incorporation” (PDF 115.61 KB) March 11, 2024 Financial Notice Concerning the Status and Completion of the Acquisition of Own Shares and Cancellation of Treasury Stock (PDF 130.35 KB) March 04, 2024 Financial Notice Concerning the Status of the Acquisition of Own Shares (PDF 112.47 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan) February 19, 2024 Corporate Terumo Blood and Cell Technologies-sponsored panel publishes first-of-its-kind international consensus recommendations for pregnancy complications in patients with sickle cell disease February 14, 2024 Corporate Terumo Medical Corporation Breaks Ground on New Manufacturing Site at Its Puerto Rico Location February 14, 2024 Corporate Hundreds of sickle cell patients to benefit from £1.5M technology investment February 12, 2024 Corporate Terumo India Certified as Great Place to Work® for The Third Time February 07, 2024 Financial Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2024 (FY2023) (PDF 82.66 KB) February 07, 2024 Financial Notice Concerning Share Split and Partial Amendment to the Articles of Incorporation (PDF 123.59 KB) February 07, 2024 Corporate Terumo Announces Change of Executive Officers (PDF 232.27 KB) February 02, 2024 Financial Notice Concerning the Status of the Acquisition of Own Shares (PDF 112.52 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan) January 09, 2024 Financial Notice Concerning the Status of the Acquisition of Own Shares (PDF 112.48 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan) Pagination Previous page ‹ Current page1 Next page ›
March 19, 2024 Corporate Terumo Blood and Cell Technologies partners with CiRA Foundation to develop automated iPS cell manufacturing iPS cell manufacturing organization researchers to integrate Terumo Blood and Cell Technologies’ Quantum Flex, expertise through collaboration
March 11, 2024 Financial Notice Concerning Partial Amendment to “Notice Concerning Share Split and Partial Amendment to the Articles of Incorporation” (PDF 115.61 KB)
March 11, 2024 Financial Notice Concerning the Status and Completion of the Acquisition of Own Shares and Cancellation of Treasury Stock (PDF 130.35 KB)
March 04, 2024 Financial Notice Concerning the Status of the Acquisition of Own Shares (PDF 112.47 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
February 19, 2024 Corporate Terumo Blood and Cell Technologies-sponsored panel publishes first-of-its-kind international consensus recommendations for pregnancy complications in patients with sickle cell disease
February 14, 2024 Corporate Terumo Medical Corporation Breaks Ground on New Manufacturing Site at Its Puerto Rico Location
February 14, 2024 Corporate Hundreds of sickle cell patients to benefit from £1.5M technology investment
February 07, 2024 Financial Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2024 (FY2023) (PDF 82.66 KB)
February 07, 2024 Financial Notice Concerning Share Split and Partial Amendment to the Articles of Incorporation (PDF 123.59 KB)
February 02, 2024 Financial Notice Concerning the Status of the Acquisition of Own Shares (PDF 112.52 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
January 09, 2024 Financial Notice Concerning the Status of the Acquisition of Own Shares (PDF 112.48 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)